Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "dyspnea"

IMBRUVICA® (ibrutinib) Now Approved in Europe for Treatment o...

SUNNYVALE, Calif. , Oct. 17, 2014 /PRNewswire/ -- Pharmacyclics, Inc. ( NASDAQ: PCYC ) today announced that the European Commission (EC) has granted marketing approval for IMBRUVICA ® (ibrutinib) throughout the 28 member states of the European ... Town Hall, 2 days ago
[x]  
Advance for Nurses

Atrial Fibrillation in a Patient With Lung Cancer

Section Sponsored by: Lung cancer is the most frequent cause of malignant pericardial effusion, accounting for 35% of reported cases.1 Pericardial effusions secondary to pericardial invasion can cause shortness of breath, orthopnea, tachycardia, ...
 Advance for Nurses2 days ago Boehringer Ingelheim Corporation's Afatinib Meets Primary Endpoint In Phase 3 Study Of Head And Neck Cancer  BioSpace2 weeks ago Head-to-head Phase III trial demonstrates superior progression-free survival of afatinib compared to erlotinib in patients with advanced squamous cell carcinoma of the lung  Wall Street Select2 weeks ago
[x]  

Cardiomyopathy Pipeline Market Review, H2 2014

RnRMarketResearch.com adds Cardiomyopathy Pipeline Review, H2 2014 report to its research database. The report provides an overview of the Cardiomyopathy's therapeutic pipeline. Dallas, TX -- (ReleaseWire) -- 10/17/2014 -- This report provides ...
 Digital Journal2 days ago

Overweight children displayed poorer asthma control than lean children

Overweight and obese children with early-onset asthma had distinct symptoms and experienced poorer asthma control compared with lean children, according to recent study results. Researchers conducted a cross-sectional study of 21 lean children ...
 Orthopedics Today3 days ago
Azonano

Monitoring heart failure with tiny implant

A new miniaturized, wireless monitoring system, implanted in the pulmonary artery, is helping keep patients with severe heart failure out of the hospital. Houston Methodist Hospital is the first institution in Houston to offer this to heart failure ...
 Science Daily3 days ago New miniaturized, wireless monitoring system for heart failure patients  News-Medical.Net5 days ago Houston Methodist Hospital Offers New CardioMEMS HF System Treatment  Azonano6 days ago Heart Failure Symptom Relationships: A Systematic Review  Medical Care3 weeks ago
Jagran Post

Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: American College of Chest Physicians and Canadian Thoracic Society Guideline

Background: Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality in the United States as well as the rest of the world. An exacerbation of COPD, periodic escalations of symptoms of cough, dyspnea and sputum ...
 CHEST3 days ago UB study: COPD patients breathe easier with Lung Flute  Pharmacy Choice4 days ago COPD Patients Breathe Easier with Lung Flute  Advance for Respiratory Care & Sleep Medicine1 week ago Lung Flute Improves COPD and Chronic Bronchitis Symptoms  Hospi Medica1 week ago
[x]  

"Diphenylmethyl Piperazine Derivative and Pharmaceutical Composition Using Same" in Patent Application Approval Process

By a News Reporter-Staff News Editor at Heart Disease Weekly A patent application by the inventor Kaneko, Noboru (Oyama-shi, JP), filed on June 15, 2012, was made available online on October 9, 2014, according to news reporting originating from ...
 Pharmacy Choice4 days ago
Securities Technology Monitor

ProMetic Life Sciences Inc. (PFSCF: OTCQX International) | ProMetic's PBI-4050 to Target Idiopathic Pulmonary Fibrosis ("IPF") as One of Its Orphan Indications

- ProMetic Life Sciences Inc. (TSX:PLI)(OTCQX:PFSCF) ("ProMetic" or the "Corporation") announced today that it will be pursuing IPF as one of its PBI-4050 orphan indications. This decision follows the completion of a favorable external review of ...
 Pink Sheets4 days ago PROMETIC LIFE SCIENCES : PBI-4050 to Target Idiopathic Pulmonary Fibrosis ("IPF") as One of Its Orphan Indications  4 Traders4 days ago PROMETICS PBI-4050 TO TARGET IDIOPATHIC PULMONARY FIBROSIS (IPF) AS ONE OF ITS ORPHAN INDICATIONS  Noodls4 days ago ProMetic's PBI-4050 to Target Idiopathic Pulmonary Fibrosis ("IPF") as One of Its Orphan Indications  Reuters4 days ago
[x]  
MedIndia

Swollen Glands

Lymph nodes play a vital role in the immune system of our body, by way of protecting from various infectious particles. These lymph nodes get swollen and become painful due to invasion into the body by bacteria, viruses, parasitic infections , ...
 MedIndia4 days ago

Sucampo Announces Extension of AMITIZA(R) (lubiprostone) License and Collaboration Agreement With Takeda

BETHESDA, Md., Oct. 14, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) ( Nasdaq:SCMP ), a global biopharmaceutical company, today announced that it signed on October 9, 2014 an amendment to the existing collaboration and license ...
 CEOWorld Magazine5 days ago Sucampo Pharmaceuticals, Inc. Release: Clinical Data For AMITIZA® Lubiprostone To Be Presented At The American College of Gastroenterology 2014 Annual Scientific Meeting  BioSpace6 days ago Clinical Data for AMITIZA(R) Lubiprostone to be Presented at the American College of Gastroenterology 2014 Annual Scientific Meeting  Stockwatch6 days ago Sucampo Pharmaceuticals : Announces Extension of AMITIZA(R) (lubiprostone) License and Collaboration Agreement With Takeda  4 Traders5 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less